Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New help and navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions label has been updated to Intervention/Treatment, with Revision updated to v3.6.0. The notice No longer looking for participants confirms that the study is not currently recruiting.
    Difference
    0.4%
    Check dated 2026-06-14T03:42:43.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, updating the revision label from v3.5.4 to v3.5.5. This is a minor metadata update and does not modify the study information or layout.
    Difference
    0.1%
    Check dated 2026-06-06T23:24:13.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-05-16T09:45:53.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a non-clinical site/software update.
    Difference
    0.1%
    Check dated 2026-04-24T22:25:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:36.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T00:18:54.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.